Site Search
  • decreaseincrease
  • pdf

Washington Regional Introduces New Prostate Biopsy Technology

Washington Regional Medical Center is proud to now offer the Artemis MRI/ultrasound fusion guided prostate biopsy system. MRI/ultrasound guided biopsy is the latest technology available in the detection and management of prostate cancer, and Washington Regional is the first health care system in Northwest Arkansas to use the Artemis system.

Historically, finding the exact location of cancer in a prostate gland has been a challenge. Conventional prostate biopsy techniques are referred to as “blind” biopsies since physicians typically cannot easily view the specific location of any abnormal tissue. The Artemis 3D imaging and navigation system combines MRI images with real-time ultrasound images to create a detailed 3D map of the prostate that allows physicians to better identify and more accurately biopsy suspicious prostate cancer areas.

“Washington Regional is proud to offer this groundbreaking and potentially life-saving technology in Northwest Arkansas,” said Mark Jackson, MD, service chair of urology department at Washington Regional Medical Center. “Prostate cancer is the second most common cancer in men after skin cancer, and 1 in 7 men will be diagnosed in their lifetime. The fusion prostate biopsy system provides patients with improved diagnosis and accuracy in the detection and treatment of prostate cancer.”

Patients recommended for this procedure are men who, typically, have elevated and/or rising prostate-specific antigen (PSA) levels or those with a clinical concern for prostate cancer. To learn more about MRI/ultrasound fusion prostate biopsy, click here.